Abstract
Through the generosity of those in charge of the distribution of tryparsamide, we have been able, during the last six months, to undertake a preliminary study to determine the value of this drug in the treatment of neurosyphilis, as well as to determine the toxicity and the untoward reactions of the drug, if such existed. In order that our study should be of value, we were careful to carry out our procedure exactly as outlined to us, and to take all the necessary precautions that were definitely given to us at the outset of our study. A large part of our material came from the psychopathic service of the University of Michigan Medical School, and, therefore, most of our cases were those of the parenchymatous type. As this particular type of case, notably the cases of general paralysis, has been least benefited with other forms of treatment, it seemed especially
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
